| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 830.53 | 7.6% |
| Total Income | 841.12 | 6.9% |
| Expenditure | 746.59 | 6.9% |
| PBT | 94.53 | 7.2% |
| Net Profit | 70.79 | 8.0% |
| OPM | 5.36% | 2.24pp |
| NPM | 8.42% | 0.09pp |
| EPS | 4.06 | 0.5% |
Ceigall India Ltd Reports 16.3% Y-o-Y Revenue Growth in 9M FY25, Upgraded by India Ratings & Research
04 Feb 2025 · 4 Feb 2025, 09:11 pm
Summary
Ceigall India Limited, an EPC company, announced its unaudited financial results for the quarter and nine months ending December 31, 2024. The company reported a 16.3% year-on-year growth in revenue from operations, reaching 24,063 million. The consolidated EBITDA stood at 3,716 million, reflecting a 10.5% year-on-year growth. The consolidated PAT rose to 2,142 million, marking a 9.2% increase. Ceigall India's order book currently stands at 1,17,025 million. The company has been upgraded by India Ratings & Research and has emerged as the L1 bidder for a 6-lane Greenfield Southern Ludhiana Hybrid Bypass project.
Key Highlights
- 1
16.3% year-on-year growth in revenue from operations
- 2
10.5% year-on-year growth in consolidated EBITDA
- 3
9.2% increase in consolidated PAT
- 4
Robust order book of 1,17,025 million
- 5
India Ratings & Research upgraded the company’s bank loans
- 6
Arbitral Tribunal has declared an award in favour of the company, directing GMADA to pay an amount of 54.2 crores along with a future simple interest of @12% from the date of the award till realization
Management Comments
Mr. Ramneek Sehgal
Managing Director
I am pleased to share that the company has delivered a healthy operating performance for the period ending 9M FY’25. Our consolidated revenue from operations (excluding bonus & royalty) increased by 16.3% to ₹24,063 mn. For the same period, our EBITDA and PAT stood at ₹3,716 mn and ₹2,142 mn, respectively. As of December 31, 2024, our total order book stands at ₹1,17,025 mn, reflecting a healthy book-to-bill ratio.
Informational and educational content only. Not investment advice.